Former President Joe Biden is entering a new phase of treatment for the prostate cancer he was diagnosed with in...
Read moreA prominent Hamas leader lost his temper and stormed off from a live interview after being pressed on the Oct....
Read morePresident Donald Trump railed against Democrats over the ongoing government shutdown Saturday, and said he is directing Secretary of War...
Read moreA prominent Hamas leader lost his temper and stormed off from a live interview after being pressed on the Oct....
Read moreVenezuelan opposition leader and newly minted Nobel Peace Prize winner María Corina Machado dedicated the award on Friday to both...
Read moreSecretary of War Pete Hegseth on Friday announced that the Department of War (DOW) is establishing a new counter-narcotics Joint...
Read moreRussian President Vladimir Putin praised President Donald Trump’s efforts to negotiate peace deals around the world, specifically citing his work...
Read morePresident Donald Trump is in ‘excellent overall health,’ the president’s doctor said in a memorandum after a follow-up evaluation at...
Read moreNorth Korean leader Kim Jong Un displayed a new long-range intercontinental ballistic missile at a military parade in Pyongyang that...
Read more‘Trump derangement syndrome’ has spiraled to pathological levels, Health and Human Services Secretary Robert F. Kennedy Jr. said during the...
Read moreDisclaimer: ProsperityPulsePoint.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.